Skip to content

Aerogen® Solo Continuous Nebulization Tube Set AG-AS3085Recalls & reported problems

Aerogen Limited · 60ml Syringe for Use in Continuous Nebulization Only · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05391517930405), received between May 25, 2023 and May 25, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Fluid/Blood Leak1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 25, 2023Fluid/Blood Leak

    PHARMACY STAFF REPORTING THAT THEY HAVE RECENTLY NOTICED LEAKING FROM THE BACK OF AEROGEN SYRINGES USED TO PREPARE VELETRI FOR INHALATION. LEAKING SYRINGES WERE NOT DISPENSED AND THESE PRODUCTS WERE RE-MADE BEFORE SENDING FOR PATIENT USE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17001674 ↗

Other Nebulizer (Direct Patient Interface) devices

All Nebulizer (Direct Patient Interface) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page